Deutsche Bank’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-810
Closed -$79K 4121
2022
Q1
$79K Sell
810
-90
-10% -$8.78K ﹤0.01% 3612
2021
Q4
$147K Buy
900
+45
+5% +$7.35K ﹤0.01% 3481
2021
Q3
$233K Sell
855
-155
-15% -$42.2K ﹤0.01% 3454
2021
Q2
$400K Sell
1,010
-81
-7% -$32.1K ﹤0.01% 3348
2021
Q1
$590K Sell
1,091
-996
-48% -$539K ﹤0.01% 2986
2020
Q4
$789K Buy
2,087
+134
+7% +$50.7K ﹤0.01% 2596
2020
Q3
$738K Buy
1,953
+45
+2% +$17K ﹤0.01% 2383
2020
Q2
$938K Buy
1,908
+911
+91% +$448K ﹤0.01% 2262
2020
Q1
$367K Buy
997
+604
+154% +$222K ﹤0.01% 2629
2019
Q4
$277K Sell
393
-184
-32% -$130K ﹤0.01% 3004
2019
Q3
$370K Buy
577
+232
+67% +$149K ﹤0.01% 2817
2019
Q2
$299K Sell
345
-17
-5% -$14.7K ﹤0.01% 3537
2019
Q1
$208K Sell
362
-117
-24% -$67.2K ﹤0.01% 3890
2018
Q4
$133K Sell
479
-2,722
-85% -$756K ﹤0.01% 3957
2018
Q3
$1.54M Buy
3,201
+1,483
+86% +$712K ﹤0.01% 2995
2018
Q2
$778K Sell
1,718
-2,520
-59% -$1.14M ﹤0.01% 3554
2018
Q1
$2.49M Buy
4,238
+2,276
+116% +$1.34M ﹤0.01% 2698
2017
Q4
$1.22M Buy
1,962
+1,148
+141% +$712K ﹤0.01% 3024
2017
Q3
$749K Sell
814
-1,589
-66% -$1.46M ﹤0.01% 3140
2017
Q2
$2.24M Buy
2,403
+1,823
+314% +$1.7M ﹤0.01% 2460
2017
Q1
$550K Sell
580
-91
-14% -$86.3K ﹤0.01% 2956
2016
Q4
$537K Sell
671
-4,044
-86% -$3.24M ﹤0.01% 3060
2016
Q3
$3.98M Sell
4,715
-101
-2% -$85.3K ﹤0.01% 1887
2016
Q2
$3.96M Buy
4,816
+4,610
+2,238% +$3.79M ﹤0.01% 1918
2016
Q1
$228K Sell
206
-485
-70% -$537K ﹤0.01% 3497
2015
Q4
$860K Sell
691
-373
-35% -$464K ﹤0.01% 2927
2015
Q3
$1.44M Buy
1,064
+421
+65% +$568K ﹤0.01% 2670
2015
Q2
$1.16M Buy
643
+176
+38% +$316K ﹤0.01% 2834
2015
Q1
$752K Buy
467
+101
+28% +$163K ﹤0.01% 2997
2014
Q4
$276K Sell
366
-323
-47% -$244K ﹤0.01% 3930
2014
Q3
$272K Sell
689
-80
-10% -$31.6K ﹤0.01% 3737
2014
Q2
$464K Buy
769
+68
+10% +$41K ﹤0.01% 3416
2014
Q1
$481K Buy
701
+446
+175% +$306K ﹤0.01% 3362
2013
Q4
$165K Sell
255
-279
-52% -$181K ﹤0.01% 3778
2013
Q3
$314K Buy
534
+265
+99% +$156K ﹤0.01% 3820
2013
Q2
$84K Buy
+269
New +$84K ﹤0.01% 4280